Here is how Alcon (ALC) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.

ALC gains after launching Clareon TruPlus IOL, expanding its portfolio with enhanced depth of focus while maintaining high-quality distance vision.

Alcon launched its Clareon TruPlus enhanced monofocal and toric IOLs in the U.S., according to a press release.The lens ...

Alcon is reaffirmed as a buy, supported by robust macro demand in eyecare and a strong product pipeline despite abandoning the STAAR Surgical acquisition. ALC demonstrates potential resilience versus ...

SINKING SPRING, Pa. -- It was another steady quarterly report by Alcon, the Switzerland-based eyecare company with manufacturing and research facilities in Berks County. The company mostly beat ...

When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be. But his ...

Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its Fort Worth campus. Alcon, which started in Fort Worth and has grown to ...

Novartis has completed the spinoff of Alcon, an eye-care company it acquired nearly a decade ago for $12.9 billion. The Basel, Switzerland-based company first announced the planned separation in June ...

Add Yahoo as a preferred source to see more of our stories on Google. Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its ...